CreativeOne Wealth’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Buy |
11,935
+2,350
| +25% | +$295K | 0.04% | 418 |
|
|
2025
Q1 | $1.06M | Buy |
9,585
+4,361
| +83% | +$482K | 0.03% | 469 |
|
|
2024
Q4 | $713K | Sell |
5,224
-3,184
| -38% | -$435K | 0.02% | 591 |
|
|
2024
Q3 | $969K | Buy |
8,408
+5,514
| +191% | +$635K | 0.03% | 441 |
|
|
2024
Q2 | $398K | Sell |
2,894
-5,059
| -64% | -$696K | 0.02% | 538 |
|
|
2024
Q1 | $1.1M | Buy |
7,953
+5,730
| +258% | +$790K | 0.04% | 357 |
|
|
2023
Q4 | $293K | Buy |
+2,223
| New | +$293K | 0.02% | 512 |
|